索引于
  • 打开 J 门
  • Genamics 期刊搜索
  • 学术钥匙
  • 期刊目录
  • 研究圣经
  • 中国知网(CNKI)
  • 西马戈
  • 乌尔里希的期刊目录
  • 电子期刊图书馆
  • 参考搜索
  • 哈姆达大学
  • 亚利桑那州EBSCO
  • OCLC-WorldCat
  • SWB 在线目录
  • 虚拟生物学图书馆 (vifabio)
  • 普布隆斯
  • 米亚尔
  • 科学索引服务 (SIS)
  • 欧洲酒吧
  • 谷歌学术
分享此页面
期刊传单
Flyer image

抽象的

Concerns Involving Nanobiotechnology in Contemporary Vaccines Include Nanobacteria, Nanocarriers, and Nanovaccines

Grisolia Christian

This review briefly discusses the issues with nanobiotechnology as it relates to the design and creation of novel vaccines using the most well-known nanocarriers, including those made by nature such as bacterial spores, virus-like particles, exosomes, and bacteriophages and by man such as Proteosomes, liposomes, virosomes, SuperFluids, and nanobeads, as well as the benefits and drawbacks Here, we concentrate on the creation of nano-based vaccines as "nanovaccines" for stimulating immune systems, as well as the anticipated benefits and drawbacks in comparison to currently available vaccines. We also discuss a possible nanorisk for vaccines, known as nanobacterial contamination.